Stocktoria

MOLINA HEALTHCARE, INC. MOH

NYSE · stock · Hospital & Medical Service Plans · website · IPO 2003-07-02 · LEI

MOLINA HEALTHCARE, INC. (MOH) earns a Piotroski F-score of 4/9 (mixed financial health), with an Altman Z″ in the safe zone. It does not currently pay a dividend. FY2025 revenue was $45.4B at a 1.0% net margin.

Chart by TradingView
53/100
Stocktoria Quality Score · grade C
4/9
Piotroski F — financial health
3.6
Altman Z″ — distress risk · safe
—
Dividend yield · no dividend

Quality score trend · recomputed for each fiscal year

Piotroski F /9
4 4 6 6 4 6 7 7 6 4 2016201720182019202020212022202320242025
Altman Z″
2.18 1.38 3.87 4.92 3.70 3.11 3.43 3.90 4.06 3.60 2016201720182019202020212022202320242025

Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.

$190.86 as of 2026-09-01 · -0.3% 1y
$133.30$228.7052-wk
Market cap USD$12.0B
P / E25.4×
Net margin 5y avg2.4%
Return on equity 5y avg23.1%
Beta0.76
Employees19,000

Analyst price target

$209.12 +9.6% vs last
consensus: hold · 17 analysts
target range $147.00 – $266.00 · median $209.00
1 strong buy · 3 buy · 14 hold · 1 strong sell
Recent analyst actions
DateFirmRating
2026-07-28Wells FargoEqual-Weight (main)
2026-07-24Truist SecuritiesHold (main)
2026-07-24RBC CapitalSector Perform (main)
2026-07-24BarclaysUnderweight (main)
2026-07-14TD CowenHold (main)
2026-07-14Truist SecuritiesHold (main)

Wall Street analyst consensus — a sentiment gauge, not our scoring.

Forward estimates · earnings calendar →

Forward EPS est.$9.75
Forward P / E19.6×
Next earnings2026-10-21

Consensus analyst estimates and scheduled dates — forward-looking, may change.

Smart money · insiders, last 12 months

Insiders net sold -$3.4M on the open market · 2 trades

Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.

Revenue trend · last 10y · up

How it ranks in Finance, Insurance & Real Estate · percentile among 1152 companies

Piotroski Fstronger than 46%
Net marginstronger than 32%
Return on equitystronger than 70%
Revenue growthstronger than 67%

Percentile vs other Finance, Insurance & Real Estate companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Altman Z″ components · safe zone

ComponentValue
Working capital / assets0.326
Retained earnings / assets0.231
EBIT / assets0.05
Equity / liabilities0.354

Sector peers · similar-size Finance, Insurance & Real Estate companies compare side by side →

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
MOHMOLINA HEALTHCARE, INC.4/93.625.4+11.7%
OSCROscar Health, Inc.4/9-2.18—+27.5%
ALHCAlignment Healthcare, Inc.5/9-0.35—+46.1%
CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE2/9-12.26—+40.3%
TRUPTRUPANION, INC.2/92.14—+11.9%
HUMHUMANA INC5/95.138.8+10.1%
CNCCENTENE CORP4/90.38—+19.4%

All Finance, Insurance & Real Estate companies →

About MOLINA HEALTHCARE, INC.

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates through Medicaid, Medicare, Marketplace, and Other segments. The company was founded in 1980 and is headquartered in Long Beach, California.

FAQ

Is MOH financially healthy?

MOLINA HEALTHCARE, INC.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.

Does MOH pay a dividend?

No, MOLINA HEALTHCARE, INC. does not currently pay a dividend.

How profitable is MOH?

In FY2025, MOLINA HEALTHCARE, INC. had a net margin of 1.0% and a return on equity of 11.6%.

Is MOH overvalued or undervalued?

MOLINA HEALTHCARE, INC. trades at about 21.4× trailing earnings — near its 10-year norm (10-year range 10.7×–61.7×, median 20.1×). Stocktoria reports the data, not buy/sell advice.

What is the analyst price target for MOH?

The average Wall-Street price target for MOLINA HEALTHCARE, INC. is $209.12, about 9.6% above the recent price, from 17 analysts (consensus: hold).

Is MOH a good stock to buy?

Stocktoria doesn't give buy or sell advice, but here is the data on MOLINA HEALTHCARE, INC.: a Piotroski F-score of 4/9, an Altman Z″ in the safe zone, a P/E of about 25.4×. Weigh these quality and valuation signals against your own goals.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.